“…Further widespread loss of DNA methylation, including at repetitive elements and imprinting control centres is observed when female ESCs are cultured in conditions that promote ground-state pluripotency, despite male ESCs tolerating such conditions (Choi et al, 2017a;Choi et al, 2017b;Habibi et al, 2013;Ooi et al, 2010;Schulz et al, 2014;Yagi et al, 2017). Female ESCs are also karyotypically unstable, with XO cells rapidly dominating cultures (Choi et al, 2017b;Yagi et al, 2017;Zvetkova et al, 2005), which is also observed in human female embryonic stem cells (Di Stefano et al, 2018). These complications additionally arise when somatic female cells are reprogrammed to induced pluripotent stem cells (iPSCs) (Milagre et al, 2017;Pasque et al, 2018;Song et al, 2019), suggesting that these are features of female pluripotency in culture that confound both research requiring such cells and future medical applications.…”